Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
697.70
3.55 (0.51%)
BSENSE

Aug 10, 03:30 PM

BSE+NSE Vol: 90.06 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

90.06 k (-21.12%) Volume

Shareholding (Jun 2026)

FII

8.78%

Held by 17 FIIs

DII

9.05%

Held by 8 DIIs

Promoter

63.85%

Why is Nephrocare Health Services Ltd falling/rising?

11-Aug-2026

As of 10-Aug, Nephrocare Health Services Ltd's stock price is 696.15, reflecting a 0.28% increase. Despite strong overall performance and being net-debt free, today's volatility and declining investor interest raise concerns about its valuation and future sentiment.

As of 10-Aug, Nephrocare Health Services Ltd's stock price is currently at 696.15, reflecting a change of 1.95 (0.28%) increase. The stock has shown a positive trend over the past week, rising by 1.31%, while the benchmark Sensex has slightly declined by 0.12%. Over the past month, the stock has performed even better, with a 7.55% increase compared to the Sensex's 1.25% rise. Year-to-date, Nephrocare's stock has surged by 48.35%, significantly outperforming the Sensex, which has dropped by 7.84%.<BR><BR>Despite this overall positive performance, today's trading session indicates some volatility. The stock opened with a loss of 2.66% and has experienced a day’s low of 675.75, although it also reached an intraday high of 709.15, showing a potential for recovery during the day. However, the stock's performance today has underperformed its sector by 1.01%. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 46.25% compared to the 5-day average, which may indicate waning interest among investors.<BR><BR>On a positive note, Nephrocare is net-debt free and has reported strong financial results, including the highest quarterly net sales and operating profit to interest ratios. However, the stock is considered to have a very expensive valuation with a return on equity (ROE) of 6.9 and a price-to-book value of 6.2. Furthermore, institutional investors have reduced their stake by 0.75% in the last quarter, which could signal a lack of confidence among more sophisticated investors.<BR><BR>In summary, while Nephrocare Health Services Ltd has shown strong performance over various periods, today's fluctuations, declining investor participation, and concerns over valuation may contribute to the mixed sentiment surrounding the stock.

View full answer

Should I buy, sell or hold Nephrocare Health Services Ltd?

05-Aug-2026

What does Nephrocare Healt do?

11-Jun-2026

Nephrocare Health Services Ltd is a small-cap healthcare company that reported net sales of 266 Cr and a net profit of 30 Cr for March 2026. Key metrics include a P/E ratio of 93.00 and a market cap of INR 7,195 Cr.

Overview: <BR>Nephrocare Health Services Ltd operates in the healthcare services industry and is classified as a small-cap company.<BR><BR>History: <BR>The incorporation year is not provided, and there are no status changes mentioned. The latest quarterly results reported are for March 2026, showing net sales and profit.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 266 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 30 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 7,195 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 93.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.31 <BR>Return on Equity: 6.88% <BR>Price to Book: 6.47 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

View full answer

How big is Nephrocare Healt?

11-Jun-2026

As of 10th June, Nephrocare Health Services Ltd has a market capitalization of 7,195.00 Cr, with net sales of 990.26 Cr and a net profit of 78.01 Cr over the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Nephrocare Health Services Ltd has a market capitalization of 7,195.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 990.26 Cr, while the sum of Net Profit for the same period is 78.01 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds stand at 584.11 Cr, and Total Assets are valued at 975.89 Cr.

View full answer

Who are the peers of the Nephrocare Healt?

11-Jun-2026

Nephrocare Healt's peers include Poly Medicure, Vijaya Diagnost., Indegene, Metropolis Healt, Thyrocare Tech., Suven Life Scie., Vimta Labs, Krsnaa Diagnost., Suraksha Diagno., and Laxmi Dental. Thyrocare Tech. leads with a 1-year return of 61.22%, while Laxmi Dental has the lowest at -48.44%.

Peers: The peers of Nephrocare Healt are Poly Medicure, Vijaya Diagnost., Indegene, Metropolis Healt, Thyrocare Tech., Suven Life Scie., Vimta Labs, Krsnaa Diagnost., Suraksha Diagno., Laxmi Dental.<BR><BR>Quality Snapshot: Excellent management risk is observed at Poly Medicure, Vijaya Diagnost., Metropolis Healt, and Thyrocare Tech., while Average management risk is found at Indegene, Vimta Labs, Krsnaa Diagnost., and Laxmi Dental. Below Average management risk is noted for Suven Life Scie. Good growth is seen at Suraksha Diagno. and Laxmi Dental, while Below Average growth is present in Poly Medicure, Vijaya Diagnost., Indegene, Metropolis Healt, Thyrocare Tech., Suven Life Scie., Vimta Labs, Krsnaa Diagnost., and the rest. Excellent capital structure is held by Poly Medicure, Vijaya Diagnost., Indegene, Metropolis Healt, Thyrocare Tech., Vimta Labs, Krsnaa Diagnost., and Laxmi Dental, while Below Average capital structure is noted for Suven Life Scie.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Thyrocare Tech. at 61.22%, while Laxmi Dental has the lowest at -48.44%. Nephrocare Healt's 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include Krsnaa Diagnost., Suraksha Diagno., and Laxmi Dental.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 6.9, it has a Very Expensive valuation with a 6.2 Price to Book Value

  • Over the past year, while the stock has generated a return of NA, its profits have risen by 15%
2

Falling Participation by Institutional Investors

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 6,927 Cr (Small Cap)

stock-summary
P/E

88.00

stock-summary
Industry P/E

69

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

6.88%

stock-summary
Price to Book

6.25

Revenue and Profits:
Net Sales:
266 Cr
(Quarterly Results - Mar 2026)
Net Profit:
30 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.03%
0%
28.03%
6 Months
30.25%
0%
30.25%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.39
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.83%
ROCE (avg)
17.70%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
88
Industry P/E
69
Price to Book Value
6.18
EV to EBIT
48.07
EV to EBITDA
28.87
EV to Capital Employed
8.51
EV to Sales
6.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.70%
ROE (Latest)
6.88%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (3.2%)

FIIs

Held by 17 FIIs (8.78%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.7%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "164.33",
          "val2": "160.66",
          "chgp": "2.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.08",
          "val2": "22.86",
          "chgp": "-3.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.27",
          "val2": "3.96",
          "chgp": "-67.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.89",
          "val2": "8.45",
          "chgp": "28.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.44%",
          "val2": "14.23%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "629.74",
          "val2": "543.60",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.16",
          "val2": "94.89",
          "chgp": "-7.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "49.76",
          "val2": "14.30",
          "chgp": "247.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.06",
          "val2": "34.24",
          "chgp": "-123.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.00%",
          "val2": "17.46%",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
164.33
160.66
2.28%
Operating Profit (PBDIT) excl Other Income
22.08
22.86
-3.41%
Interest
1.27
3.96
-67.93%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.89
8.45
28.88%
Operating Profit Margin (Excl OI)
13.44%
14.23%
-0.79%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
629.74
543.60
15.85%
Operating Profit (PBDIT) excl Other Income
88.16
94.89
-7.09%
Interest
49.76
14.30
247.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
-8.06
34.24
-123.54%
Operating Profit Margin (Excl OI)
14.00%
17.46%
-3.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Nephrocare Health Services Ltd stock-summary
stock-summary
Nephrocare Health Services Ltd
Small Cap
Healthcare Services
Nephrocare Health Services Limited was incorporated as "Nephrocare Health Services Private Limited", a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009.
Company Coordinates stock-summary
Icon
No Company Details Available